comparemela.com
  1. Home
  2. Live Updates
  3. Chemomab Therapeutics (CMMB) Awarded New Patents for CM-101, Its First-in Class Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases : comparemela.com

Chemomab Therapeutics (CMMB) Awarded New Patents for CM-101, Its First-in Class Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases

Chemomab Therapeutics (CMMB) Awarded New Patents for CM-101, Its First-in Class Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Brazil ,Israel ,Israeli ,Brazilian ,Wadi Mor ,Chemomab Therapeutics Ltd ,European Union ,Nasdaq ,Chemomab Therapeutics ,Patent Offices ,That Recognize Additional ,Chief Executive Officer ,Chief Scientific Officer ,Orphan Drug ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.